title: Randomized, double-blind comparison of Omnipaque 300 and Hypaque 60 in patients undergoing bolus-enhanced dynamic computed body tomography.
authors.affiliation: Medical Department, Winthrop Pharmaceuticals, New York, New York.
authors.forename: P C
authors.initials: PC
authors.lastname: Brown
authors.forename: M E
authors.initials: ME
authors.lastname: Bernardino
authors.forename: E K
authors.initials: EK
authors.lastname: Fishman
authors.forename: R B
authors.initials: RB
authors.lastname: Jeffrey
mesh_terms: D000328:Adult; D003973:Diatrizoate / Q000009:adverse effects; D004311:Double-Blind Method; D006801:Humans; D007472:Iohexol / Q000009:adverse effects; D011446:Prospective Studies; D014057:Tomography, X-Ray Computed / Q000379:methods* / Q000706:statistics & numerical data
chemical_list: D003973:Diatrizoate; D007472:Iohexol